ALLO Insider Trading

Insider Ownership Percentage: 24.30%
Insider Buying (Last 12 Months): $5,000,681.30
Insider Selling (Last 12 Months): $76,536.00

Allogene Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allogene Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allogene Therapeutics Share Price & Price History

Current Price: $2.82
Price Change: Price Increase of +0.02 (0.71%)
As of 10/30/2024 01:09 PM ET

This chart shows the closing price history over time for ALLO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allogene Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/30/2024Franz B HumerDirectorSell11,200$2.34$26,208.00255,253View SEC Filing Icon  
5/16/2024Arie BelldegrunDirectorBuy1,724,137$2.90$4,999,997.301,724,137View SEC Filing Icon  
1/30/2024Geoffrey M ParkerCFOBuy190$3.60$684.00819,590View SEC Filing Icon  
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.0062,456View SEC Filing Icon  
8/7/2023Stephen MayoDirectorSell10,000$4.29$42,900.0025,328View SEC Filing Icon  
2/13/2023Veer BhavnagriGeneral CounselSell3,000$6.85$20,550.00577,677View SEC Filing Icon  
1/17/2023Veer BhavnagriGeneral CounselSell3,000$7.04$21,120.00580,677View SEC Filing Icon  
12/15/2022Veer BhavnagriGeneral CounselSell5,602$7.53$42,183.06583,677View SEC Filing Icon  
8/11/2022Owen N. WitteDirectorSell10,000$16.50$165,000.00223,271View SEC Filing Icon  
8/2/2022Rafael AmadoCMOSell2,000$11.97$23,940.00540,257View SEC Filing Icon  
7/5/2022Rafael AmadoCMOSell2,000$11.44$22,880.00542,257View SEC Filing Icon  
6/22/2022Owen N. WitteDirectorSell10,000$11.76$117,600.00233,271View SEC Filing Icon  
6/21/2022Rafael AmadoCMOSell2,000$11.18$22,360.00544,257View SEC Filing Icon  
5/19/2022Rafael AmadoCMOSell11,500$7.40$85,100.00546,257View SEC Filing Icon  
3/15/2022Alison MooreInsiderSell8,698$7.63$66,365.74View SEC Filing Icon  
3/15/2022David D ChangCEOSell23,648$7.65$180,907.20View SEC Filing Icon  
3/15/2022Eric Thomas SchmidtCFOSell11,469$7.63$87,508.47View SEC Filing Icon  
3/15/2022Rafael AmadoCMOSell5,169$7.71$39,852.99View SEC Filing Icon  
3/15/2022Veer BhavnagriGeneral CounselSell8,849$7.68$67,960.32View SEC Filing Icon  
1/12/2022Arie BelldegrunDirectorBuy155,039$12.60$1,953,491.40View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allogene Therapeutics (NASDAQ:ALLO)

83.63% of Allogene Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Allogene Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/25/2024China Universal Asset Management Co. Ltd.40,219$0.11M0.0%+64.0%0.019%Search for SEC Filing on Google Icon
10/22/2024Private Advisor Group LLC12,087$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
10/11/2024Creative Planning61,396$0.17M0.0%+108.7%0.029%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC60,675$0.17M0.0%+25.5%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC46,967$0.13M0.0%+252.7%0.022%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC2,725,000$6.35M0.2%N/A1.304%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC14,808$35K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC418,699$0.98M0.0%+46.2%0.200%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP2,228,295$5.19M1.9%N/A1.066%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company480,381$1.12M0.0%+70.3%0.230%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC27,287$64K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/15/2024Caxton Associates LP466,110$1.09M0.0%+8.1%0.223%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC126,628$0.30M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC76,160$0.18M0.0%-37.1%0.036%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC44,664$0.10M0.0%-17.5%0.021%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.25,333$59K0.0%-31.8%0.012%Search for SEC Filing on Google Icon
8/9/2024Primecap Management Co. CA5,670,226$13.21M0.0%+4.1%2.713%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC1,747,955$4.07M0.0%+340.4%0.836%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP2,550,640$5.94M0.0%+24.8%1.220%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.12,300$29K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.163,539$0.38M0.0%+31.8%0.078%Search for SEC Filing on Google Icon
8/7/2024Daiwa Securities Group Inc.26,360$61K0.0%-13.7%0.013%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC125,030$0.29M0.0%-22.2%0.060%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System40,915$95K0.0%+36.1%0.020%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc799,340$1.86M0.0%+82.7%0.382%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers164,508$0.38M0.0%+8.2%0.079%Search for SEC Filing on Google Icon
7/31/2024Rothschild Investment LLC22,200$52K0.0%N/A0.011%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.16,836$39K0.0%-45.3%0.008%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp362,364$0.84M0.0%+20.6%0.173%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC10,767$25K0.0%+429.6%0.005%Search for SEC Filing on Google Icon
7/17/2024Phoenix Wealth Advisors13,000$30K0.0%N/A0.006%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC13,316$31K0.0%-62.1%0.006%Search for SEC Filing on Google Icon
7/11/2024Bourgeon Capital Management LLC132,455$0.31M0.1%+131.6%0.063%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System107,830$0.48M0.0%-4.1%0.063%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP431,186$1.93M0.1%-44.4%0.253%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD4,177,619$18.68M0.0%+76.2%2.447%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC29,815$0.13M0.1%-21.4%0.017%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co17,750$79K0.0%+85.1%0.010%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,207,564$36.69M0.0%-9.1%4.808%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC17,396$78K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC286,408$1.28M0.1%N/A0.168%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC35,158$0.16M0.0%-34.3%0.021%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets59,820$0.27M0.0%-51.6%0.035%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.361,913$1.77M0.0%+85.1%0.212%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.30,771$0.14M0.0%-11.1%0.018%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.32,348$0.15M0.0%+66.2%0.019%Search for SEC Filing on Google Icon
4/19/2024Bourgeon Capital Management LLC57,200$0.26M0.1%+12.8%0.034%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC160,623$0.72M0.0%-3.2%0.095%Search for SEC Filing on Google Icon
2/14/2024Caxton Associates LP775,093$2.49M0.1%+61.4%0.461%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP128,400$0.41M0.1%N/A0.076%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP222,112$0.71M0.5%N/A0.132%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC400,000$1.28M0.2%N/A0.238%Search for SEC Filing on Google Icon
2/12/2024RPO LLC14,333$46K0.1%N/A0.009%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA5,281,886$16.96M0.0%0.0%3.139%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.221,094$0.74M0.0%+20.2%0.131%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets123,518$0.40M0.0%-78.3%0.073%Search for SEC Filing on Google Icon
2/7/2024Calton & Associates Inc.21,060$68K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/6/2024Axxcess Wealth Management LLC10,677$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC165,978$0.53M0.0%N/A0.099%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank214,800$0.69M0.0%+11.6%0.128%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.14,283$46K0.0%+23.1%0.008%Search for SEC Filing on Google Icon
1/31/2024Daiwa Securities Group Inc.32,498$0.10M0.0%+116.3%0.019%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank22,551$72K0.0%+55.4%0.013%Search for SEC Filing on Google Icon
1/30/2024Bourgeon Capital Management LLC50,700$0.16M0.0%-17.8%0.030%Search for SEC Filing on Google Icon
1/30/2024Cornercap Investment Counsel Inc.60,634$0.20M0.0%N/A0.036%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.18,000$58K0.0%+28.6%0.011%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC517,581$1.66M0.0%N/A0.308%Search for SEC Filing on Google Icon
1/26/2024Aaron Wealth Advisors LLC10,729$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.195,480$0.63M0.0%-54.4%0.116%Search for SEC Filing on Google Icon
1/24/2024Arizona State Retirement System30,458$98K0.0%+22.2%0.018%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.19,467$62K0.0%+353.0%0.012%Search for SEC Filing on Google Icon
1/18/2024McGlone Suttner Wealth Management Inc.8,376$27K0.0%N/A0.005%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC53,484$0.17M0.0%N/A0.032%Search for SEC Filing on Google Icon
1/10/2024Nordea Investment Management AB740,683$2.38M0.0%-3.1%0.440%Search for SEC Filing on Google Icon
1/8/2024Harbor Capital Advisors Inc.73,510$0.24M0.0%+7.3%0.044%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC36,040$0.12M0.0%+34.0%0.021%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.10,587,804$33.56M0.0%+41.1%6.292%Search for SEC Filing on Google Icon
11/24/2023EP Wealth Advisors LLC10,850$34K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/15/2023Alps Advisors Inc.123,718$0.39M0.0%+15.4%0.074%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.12,628$40K0.0%-52.5%0.008%Search for SEC Filing on Google Icon
11/14/2023Caxton Associates LP480,104$1.52M0.2%+590.0%0.285%Search for SEC Filing on Google Icon
11/14/2023MBB Public Markets I LLC57,306$0.18M0.0%-33.2%0.034%Search for SEC Filing on Google Icon
11/14/2023Primecap Management Co. CA5,284,386$16.75M0.0%-6.3%3.140%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC130,639$0.41M0.0%-4.8%0.078%Search for SEC Filing on Google Icon
11/13/2023FMR LLC25,143,931$79.71M0.0%+0.9%14.942%Search for SEC Filing on Google Icon
11/13/2023Nordea Investment Management AB764,488$2.42M0.0%-1.4%0.454%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC904,403$2.87M0.0%+2.2%0.537%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.338,756$1.07M0.0%+20.4%0.201%Search for SEC Filing on Google Icon
11/8/2023Dorsey & Whitney Trust CO LLC12,265$39K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank192,400$0.61M0.0%+3.0%0.115%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC786,793$2.50M0.0%+17.6%0.469%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.11,603$37K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/6/2023Ieq Capital LLC66,178$0.21M0.0%+45.4%0.039%Search for SEC Filing on Google Icon
11/2/2023Principal Financial Group Inc.266,154$0.84M0.0%+1.7%0.159%Search for SEC Filing on Google Icon
11/1/2023Bourgeon Capital Management LLC61,700$0.20M0.0%-7.8%0.037%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc237,836$0.75M0.0%+19.2%0.142%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.428,493$1.36M0.0%+8.3%0.256%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.68,519$0.22M0.0%+18.0%0.041%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC669,197$3.33M0.0%+33.7%0.399%Search for SEC Filing on Google Icon
8/14/2023Partners Capital Investment Group LLP454,845$2.26M0.0%+387.8%0.271%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Allogene Therapeutics logo
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
Read More on Allogene Therapeutics

Today's Range

Now: $2.82
Low: $2.73
High: $3.01

50 Day Range

MA: $2.69
Low: $2.41
High: $2.96

52 Week Range

Now: $2.82
Low: $2.01
High: $5.78

Volume

1,195,167 shs

Average Volume

2,448,455 shs

Market Capitalization

$589.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of Allogene Therapeutics?

Allogene Therapeutics' top insider shareholders include:
  1. Arie Belldegrun (Director)
  2. Geoffrey M Parker (CFO)
  3. Veer Bhavnagri (General Counsel)
  4. Franz B Humer (Director)
  5. Deborah M Messemer (Director)
  6. Stephen Mayo (Director)
Learn More about top insider investors at Allogene Therapeutics.

Who are the major institutional investors of Allogene Therapeutics?

Allogene Therapeutics' top institutional shareholders include:
  1. Creative Planning — 0.03%
  2. Exchange Traded Concepts LLC — 0.03%
  3. SG Americas Securities LLC — 0.02%
  4. China Universal Asset Management Co. Ltd. — 0.02%
  5. Private Advisor Group LLC — 0.01%
Learn More about top institutional investors of Allogene Therapeutics stock.

Which institutional investors are buying Allogene Therapeutics stock?

Within the last quarter, ALLO stock was bought by institutional investors including:
  1. SG Americas Securities LLC
  2. Creative Planning
  3. China Universal Asset Management Co. Ltd.
  4. Exchange Traded Concepts LLC
  5. Private Advisor Group LLC
During the previous year, these company insiders have bought Allogene Therapeutics stock:
  1. Arie Belldegrun (Director)
  2. Geoffrey M Parker (CFO)
Learn More investors buying Allogene Therapeutics stock.